Are Bigger Data Sets Better for Machine Learning? Fusing Single-Point and Dual-Event Dose Response Data for Mycobacterium tuberculosis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Chemical Information and Modeling

• Publication date

  2014-07-28

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1021/ci500264rPMID 24968215PMCID PMC4951206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bayesian models for screening and TB Mobile for target inference with Mycobacterium tuberculosis.

  2014cited by this paper
• Looking Back to the Future: Predicting in Vivo Efficacy of Small Molecules versus Mycobacterium tuberculosis

  2014cited by this paper
• Computational Models for Neglected Diseases: Gaps and Opportunities

  2014cited by this paper
• New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects.

  2014cited by this paper
• Computational models for tuberculosis drug discovery.

  2013cited by this paper
• Fusing Dual-Event Data Sets for Mycobacterium tuberculosis Machine Learning Models and Their Evaluation

  2013cited by this paper
• Using Graph Indices for the Analysis and Comparison of Chemical Datasets

  2013cited by this paper
• A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.

  2013cited by this paper
• Enhancing Hit Identification in Mycobacterium tuberculosis Drug Discovery Using Validated Dual-Event Bayesian Models

  2013cited by this paper
• Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.

  2013cited by this paper
• Discovery of Novel Antimalarial Compounds Enabled by QSAR-Based Virtual Screening

  2013cited by this paper
• Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.

  2013cited by this paper
• Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis

  2013cited by this paper
• Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?

  2013cited by this paper
• Dispensing Processes Impact Apparent Biological Activity as Determined by Computational and Statistical Analyses

  2013cited by this paper
• Combining Computational Methods for Hit to Lead Optimization in Mycobacterium Tuberculosis Drug Discovery

  2013cited by this paper
• Phenotypic screens as a renewed approach for drug discovery.

  2013cited by this paper
• Bayesian models leveraging bioactivity and cytotoxicity information for drug discovery.

  2013cited by this paper
• Liver-stage malaria parasites vulnerable to diverse chemical scaffolds

  2012cited by this paper
• Computational models for in-vitro anti-tubercular activity of molecules based on high-throughput chemical biology screening datasets

  2012cited by this paper
• Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis.

  2012cited by this paper
• Towards a gold standard: regarding quality in public domain chemistry databases and approaches to improving the situation.

  2012cited by this paper
• High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv.

  2012cited by this paper
• Predictive models for anti-tubercular molecules using machine learning on high-throughput biological screening datasets

  2011cited by this paper
• Impact of high-throughput screening in biomedical research

  2011cited by this paper
• Identifying apicoplast‐targeting antimalarials using high‐throughput compatible approaches

  2011cited by this paper
• A quality alert and call for improved curation of public chemistry databases.

  2011cited by this paper
• Depletion of antibiotic targets has widely varying effects on growth

  2011cited by this paper
• Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.

  2011cited by this paper
• Validating New Tuberculosis Computational Models with Public Whole Cell Screening Aerobic Activity Datasets

  2011cited by this paper
• The challenge of new drug discovery for tuberculosis

  2011cited by this paper
• Chemical Space: Missing Pieces in Cheminformatics

  2010cited by this paper
• When pharmaceutical companies publish large datasets: an abundance of riches or fool's gold?

  2010cited by this paper
• Chemical genetics of Plasmodium falciparum

  2010cited by this paper
• Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis.

  2010cited by this paper
• Meta-analysis of molecular property patterns and filtering of public datasets of antimalarial “hits” and drugs

  2010cited by this paper
• A collaborative database and computational models for tuberculosis drug discovery.

  2010cited by this paper
• Thousands of chemical starting points for antimalarial lead identification

  2010cited by this paper
• Using Open Source Computational Tools for Predicting Human Metabolic Stability and Additional Absorption, Distribution, Metabolism, Excretion, and Toxicity Properties

  2010cited by this paper
• Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery.

  2009cited by this paper
• Antituberculosis activity of the molecular libraries screening center network library.

  2009cited by this paper
• High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.

  2009cited by this paper
• In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen

  2008cited by this paper
• Global Bayesian Models for the Prioritization of Antitubercular Agents

  2008cited by this paper
• Computational Approaches That Predict Metabolic Intermediate Complex Formation with CYP3A4 (+b5)

  2007cited by this paper
• Drugs for bad bugs: confronting the challenges of antibacterial discovery

  2007cited by this paper
• Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure

  2007cited by this paper
• Cheminformatics analysis and learning in a data pipelining environment

  2006cited by this paper
• Improved Naïve Bayesian Modeling of Numerical Data for Absorption, Distribution, Metabolism and Excretion (ADME) Property Prediction

  2006cited by this paper
• The magic bullets and tuberculosis drug targets.

  2005cited by this paper
• A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

  2005cited by this paper
• Using Extended-Connectivity Fingerprints with Laplacian-Modified Bayesian Analysis in High-Throughput Screening Follow-Up

  2005cited by this paper
• New Small-Molecule Synthetic Antimycobacterials

  2005cited by this paper
• Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates.

  2003cited by this paper
• Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs.

  2000cited by this paper
• Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• Erratum: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• The properties of known drugs. 1. Molecular frameworks.

  1996cited by this paper

• Tuberculosis Drug Discovery in the Age of Artificial Intelligence.

  2025cites this paper
• Machine Learning in Tuberculosis Research: A Global Bibliometric Analysis of Diagnostic, Prognostic, and Drug Discovery Trends

  2025cites this paper
• The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applications

  2024cites this paper
• Explainable AI (XAI)-driven vibration sensing scheme for surface quality monitoring in a smart surface grinding process

  2023cites this paper
• High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents

  2023cites this paper
• Machine learning in medication prescription: A systematic review

  2023cites this paper
• Technology acceptance prediction of robo-advisors by machine learning

  2023cites this paper
• Investigation of Information gain and Chi test feature selection methods in dimensionality reduction using Machine learning for drug discovery

  2022cites this paper
• Mycobacterium abscessus drug discovery using machine learning.

  2022cites this paper
• Quantum Machine Learning Algorithms for Drug Discovery Applications

  2021cites this paper
• Use of Artificial Intelligence and Machine Learning for Discovery of Drugs for Neglected Tropical Diseases

  2021cites this paper
• Machine learning models identify molecules active against the Ebola virus in vitro [version 1; peer review: 2 approved]

  2021cites this paper
• Machine Learning Models for Mycobacterium tuberculosis In Vitro Activity: Prediction and Target Visualization.

  2021cites this paper
• Quantum Machine Learning for Drug Discovery

  2020cites this paper
• Cinnamic Derivatives as Antitubercular Agents: Characterization by Quantitative Structure–Activity Relationship Studies

  2020cites this paper
• Molecule Property Analyses of Active Compounds for Mycobacterium Tuberculosis.

  2020cites this paper
• A Very Large-Scale Bioactivity Comparison of Deep Learning and Multiple Machine Learning Algorithms for Drug Discovery

  2020cites this paper
• Bioactivity Comparison across Multiple Machine Learning Algorithms Using over 5000 Datasets for Drug Discovery.

  2020cites this paper
• Development of Cyber-Physical Security Testbed Based on IEC 61850 Architecture

  2019cites this paper
• Survey of Machine Learning Techniques in Drug Discovery.

  2019cites this paper
• Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.

  2019cites this paper
• Intrabacterial Metabolism Obscures the Successful Prediction of an InhA Inhibitor of Mycobacterium tuberculosis.

  2019cites this paper
• Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery.

  2018influential citation
• Accessible Machine Learning Approaches for Toxicology

  2018cites this paper
• Developing Next Generation Tools for Computational Toxicology

  2018cites this paper
• Machine learning models identify molecules active against the Ebola virus in vitro (version 1; referees: 2 approved)

  2017cites this paper
• Collaborative drug discovery for More Medicines for Tuberculosis (MM4TB).

  2017cites this paper
• 1 Accessible Machine Learning Approaches for Toxicology

  2017cites this paper
• Finding small molecules for the ‘ next

  2017cites this paper
• Comparison of Deep Learning With Multiple Machine Learning Methods and Metrics Using Diverse Drug Discovery Data Sets.

  2017cites this paper
• Open Source Bayesian Models. 3. Composite Models for Prediction of Binned Responses

  2016cites this paper
• The Next Era: Deep Learning in Pharmaceutical Research

  2016cites this paper
• Big data analytics and big data science: a survey

  2016cites this paper
• Predicting Mouse Liver Microsomal Stability with “Pruned” Machine Learning Models and Public Data

  2016cites this paper
• Machine Learning Model Analysis and Data Visualization with Small Molecules Tested in a Mouse Model of Mycobacterium tuberculosis Infection (2014–2015)

  2016cites this paper
• Open Peer Review

  2016cites this paper
• Combining Metabolite-Based Pharmacophores with Bayesian Machine Learning Models for Mycobacterium tuberculosis Drug Discovery

  2015cites this paper
• Machine learning models identify molecules active against the Ebola virus in vitro

  2015cites this paper
• Open Source Bayesian Models. 2. Mining a "Big Dataset" To Create and Validate Models with ChEMBL

  2015cites this paper
• Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery

  2015cites this paper
• Finding small molecules for the ‘next Ebola’

  2015cites this paper
• Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets

  2015cites this paper
• Bigger data, collaborative tools and the future of predictive drug discovery

  2014cites this paper